Vol 18, No 2 (2015)
Research paper
Published online: 2015-07-31

open access

Page views 1617
Article views/downloads 1611
Get Citation

Connect on Social Media

Connect on Social Media

Long bone metastases as predictors of survival in patients with metastatic renal cancer

Agnieszka Giżewska, Ewa Witkowska-Patena, Zofia Stembrowicz-Nowakowska, Andrzej Mazurek, Sebastian Osiecki, Łukasz Kowalski, Mirosław Dziuk, Marta Slomka
DOI: 10.5603/NMR.2015.0021
Pubmed: 26315869
Nucl. Med. Rev 2015;18(2):89-91.

Abstract

BACKGROUND: The aim of this study was to assess the prevalence of long bone metastases in renal cancer patients and to evaluate their utility as predictors of survival in this group.

MATERIAL AND METHODS: This retrospective study included 20 patients with metastatic renal cancer and bone metastases. The patients were referred for regular bone scintigraphy in order to assess disease spread in the skeleton. The patients were divided into two groups: those with 1) metastases in the skeleton (including long bones) and those with 2) metastases in the axial skeleton only.

RESULTS: Bone scintigraphy imaging was performed regularly up to 81 months from the first positive bone scan. During that time 11 deaths (8 among patients with long bone lesions) were recorded. Kaplan-Meyer curves showed that patients with long bone metastases tend to have lower survival probability in comparison to the ones with metastases in other bones.

CONCLUSIONS: Bone metastases localization seems to influence survival in patients with renal cancer. Long bone-involving spread of the disease is associated with worse survival probability than the spread to the other bones.